Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,892
Total Claims
$1.2M
Drug Cost
480
Beneficiaries
$2,563
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+76%
Opioid rate vs peers
4.5% vs 2.6% avg
+140%
Cost per patient vs peers
$2,563 vs $1,068 avg
+86%
Brand preference vs peers
16.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.5%
Opioid Rate
450
Opioid Claims
$28K
Opioid Cost
7.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,637 claims · $1.1M
Generic: 8,128 claims · $166K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 112 | $116K |
| Semaglutide | 57 | $64K |
| Fluticasone/Umeclidin/Vilanter | 70 | $55K |
| Dulaglutide | 38 | $53K |
| Dapaglifloz Propaned/Metformin | 59 | $49K |
| Empagliflozin | 30 | $43K |
| Insulin Glargine,hum.Rec.Anlog | 77 | $43K |
| Lipase/Protease/Amylase | 11 | $41K |
| Rivaroxaban | 36 | $39K |
| Insulin Regular, Human | 21 | $28K |
| Sitagliptin Phos/Metformin Hcl | 21 | $26K |
| Empagliflozin/Metformin Hcl | 19 | $25K |
| Insulin Regular, Human | 15 | $24K |
| Insulin Degludec | 41 | $20K |
| Budesonide/Formoterol Fumarate | 26 | $19K |
Prescribing Profile
Patient Profile
72
Avg Age
64%
Female
0.99
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data